Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Xerostomia Therapeutics Industry Expansion: How the Market Size Has Grown Over the Last 5 Years?
In recent years, there has been a robust growth in the market size for xerostomia therapeutics. The market is expected to expand from a valuation of $2.14 billion in 2024 to $2.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.7%. The growth witnessed during the historical period can be linked to factors such as a rise in xerostomia occurrences among the elderly, advancements in research and development for effective xerostomia solutions, increased awareness around products related to xerostomia, an upward trend in various medical conditions, and a higher prevalence of chronic ailments.
In the coming years, the xerostomia therapeutics market is projected to experience robust growth. The market is predicted to expand to $2.79 billion by 2029, with a compound annual growth rate (CAGR) of 5.3%. This growth during the forecast period is credited to factors such as the ready availability of economical medicines, a climb in oral health conditions, an increase in awareness among healthcare professionals, governmental schemes, and heightened usage of medication. The forecast period is expected to see trends such as artificial saliva and saliva replacements, advancements in technology and product innovation, personalised medicine and targeted therapies, telehealth and remote monitoring, and the surge of non-invasive treatments.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Growth Drivers Are Responsible for Accelerating Xerostomia Therapeutics Market Growth?
The xerostomia therapeutics market is projected to grow due to the mounting implementation of chemotherapy in cancer treatment. Chemotherapy, a potent medication, is used primarily to halt or decelerate the proliferation of cancer cells. The acceptance rate of chemotherapy is on the rise due to its exceptional effectiveness in specifically targeting and eliminating malignant cells throughout the body. Saliva-stimulating medications or mouth rinses fall under the umbrella of xerostomia therapeutics. These treatments help improve saliva production and enhance taste perception, thus enabling patients to maintain proper nutrition by making eating easier.
For instance, as per the National Cancer Institute, a US-based government agency, there were an estimated 18.1 million cancer survivors in the United States in January 2022, which represents 5.4% of the total population. By 2032, this number is predicted to rise to a staggering 22.5 million cancer survivors worldwide, marking a 24.4% increase from the current estimate. Hence, the growing use of chemotherapy in cancer treatment plays a significant role in driving the xerostomia therapeutics market growth.
Performance of Leading Segments in the Xerostomia Therapeutics Global Market
The xerostomia therapeutics market covered in this report is segmented –
1) By Type: Artificial Saliva Or Saliva Substitutes, Salivary Stimulants
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Hypermarkets And Supermarkets
3) By End-User: Adult, Pediatric
Subsegments:
1) By Artificial Saliva Or Saliva Substitutes: Oral Sprays, Gels, Lozenges, Mouthwashes
2) By Salivary Stimulants: Prescription Drugs, Over-The-Counter (Otc) Products, Chewing Gums And Lozenges
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the upcoming Trends Poised to Transform the Future of the Xerostomia Therapeutics Market?
Top companies in the xerostomia therapeutics market are focusing on creating patient-centric, non-invasive solutions like oral sprays to fulfill the need for effective and convenient treatment options for dry mouth. These sprays allow for accurate targeting of the affected parts of the mouth, providing efficient hydration and lubrication right where it’s required. For example, K Pharmaceuticals, a pharmaceutical firm based in India, introduced Aquoral in July 2023. This clinically tested oral spray was developed to alleviate dry mouth symptoms, also referred to as xerostomia, which can be a side effect of various medications and diseases, and can result in discomfort, difficulties in chewing and swallowing, as well as complications related to oral health. Aquoral offers long-lasting relief for up to six hours by creating a durable protective layer on the oral cavity, minimizing moisture loss and improving comfort. Instead of customary water-based treatments that necessitate regular reapplication, Aquoral utilizes patented Oxidized Glycerol Triesters (OGT), a plant-sourced, lipid-focused technology that offers superior protection.
What Are the Regional Hotspots for Xerostomia Therapeutics Market Growth?
North America was the largest region in the xerostomia therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xerostomia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Companies Hold the Largest Market Share in the Xerostomia Therapeutics Industry?
Major companies operating in the xerostomia therapeutics market are Bayer AG, 3M Company, GlaxoSmithKline plc, Colgate-Palmolive Company, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Cipla Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Synedgen Inc., Sunstar Suisse S.A., Advanz Pharma Corp., Pharmascience Inc., Mission Pharmacal Company, Dentaid Ltd., Cyclacel Pharmaceuticals Inc., Parnell Pharmaceuticals Holdings Ltd., Teva Pharmaceutical Industries Ltd., Forward Science Holding Inc., ICPA Health Products Ltd., CCMed Ltd., Bio Cosmetics Laboratories S.L., Quest Products LLC, Acacia Pharma, Saliwell Limited, OraCoat, Oralieve UK Ltd., OraPharma Inc., OraVital Inc
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=15700
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
